These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35920332)

  • 21. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.
    Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S
    J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of combinations of gapmer antisense oligonucleotides on the target reduction.
    Yanagidaira M; Yoshioka K; Nagata T; Nakao S; Miyata K; Yokota T
    Mol Biol Rep; 2023 Apr; 50(4):3539-3546. PubMed ID: 36787053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gapmer Antisense Oligonucleotides to Selectively Suppress the Mutant Allele in COL6A Genes in Dominant Ullrich Congenital Muscular Dystrophy.
    Aguti S; Marrosu E; Muntoni F; Zhou H
    Methods Mol Biol; 2020; 2176():221-230. PubMed ID: 32865794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo.
    Gupta N; Fisker N; Asselin MC; Lindholm M; Rosenbohm C; Ørum H; Elmén J; Seidah NG; Straarup EM
    PLoS One; 2010 May; 5(5):e10682. PubMed ID: 20498851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4'-BNA/LNA with 9-(aminoethoxy)phenoxazine.
    Matsubayashi T; Yoshioka K; Lei Mon SS; Katsuyama M; Jia C; Yamaguchi T; Hara RI; Nagata T; Nakagawa O; Obika S; Yokota T
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102161. PubMed ID: 38978695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to improve the design of gapmer antisense oligonucleotide on allele-specific silencing.
    Aguti S; Cheng S; Ala P; Briggs S; Muntoni F; Zhou H
    Mol Ther Nucleic Acids; 2024 Sep; 35(3):102237. PubMed ID: 38993932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.
    Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP
    Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allele-specific antisense oligonucleotides for the treatment of BEST1-related dominantly inherited retinal diseases: An in vitro model.
    Karaosmanoglu B; Imren G; Utine E; Taylan Sekeroglu H; Taskiran EZ
    Exp Eye Res; 2024 Apr; 241():109833. PubMed ID: 38369231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vivo Administration of Therapeutic Antisense Oligonucleotides.
    Statello L; Ali MM; Kanduri C
    Methods Mol Biol; 2021; 2254():273-282. PubMed ID: 33326082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals.
    Swayze EE; Siwkowski AM; Wancewicz EV; Migawa MT; Wyrzykiewicz TK; Hung G; Monia BP; Bennett CF
    Nucleic Acids Res; 2007; 35(2):687-700. PubMed ID: 17182632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smurf1 Silencing Using a LNA-ASOs/Lipid Nanoparticle System to Promote Bone Regeneration.
    García-García P; Ruiz M; Reyes R; Delgado A; Évora C; Riancho JA; Rodríguez-Rey JC; Pérez-Campo FM
    Stem Cells Transl Med; 2019 Dec; 8(12):1306-1317. PubMed ID: 31631568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of gapmer antisense oligonucleotide with deoxyribonucleic guanidine (DNG) modifications.
    Kojima N; Shrestha AR; Akisawa T; Piao H; Kizawa H; Ohmiya Y; Kurita R
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):258-269. PubMed ID: 31556356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells.
    Castanotto D; Lin M; Kowolik C; Wang L; Ren XQ; Soifer HS; Koch T; Hansen BR; Oerum H; Armstrong B; Wang Z; Bauer P; Rossi J; Stein CA
    Nucleic Acids Res; 2015 Oct; 43(19):9350-61. PubMed ID: 26433227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension.
    Yasuhara H; Yoshida T; Sasaki K; Obika S; Inoue T
    Mol Diagn Ther; 2022 Jan; 26(1):117-127. PubMed ID: 34994962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.
    Kasuya T; Hori S; Watanabe A; Nakajima M; Gahara Y; Rokushima M; Yanagimoto T; Kugimiya A
    Sci Rep; 2016 Jul; 6():30377. PubMed ID: 27461380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
    Hara RI; Yoshioka K; Yokota T
    Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides.
    Yoshida T; Morihiro K; Naito Y; Mikami A; Kasahara Y; Inoue T; Obika S
    Nucleic Acids Res; 2022 Jul; 50(13):7224-7234. PubMed ID: 35801870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LNA oligonucleotide mediates an anti-inflammatory effect in autoimmune myocarditis via targeting lactate dehydrogenase B.
    Bockstahler M; Salbach C; Müller AM; Kübler A; Müller OJ; Katus HA; Frey N; Kaya Z
    Immunology; 2022 Feb; 165(2):158-170. PubMed ID: 34606637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.
    Prakash TP; Graham MJ; Yu J; Carty R; Low A; Chappell A; Schmidt K; Zhao C; Aghajan M; Murray HF; Riney S; Booten SL; Murray SF; Gaus H; Crosby J; Lima WF; Guo S; Monia BP; Swayze EE; Seth PP
    Nucleic Acids Res; 2014 Jul; 42(13):8796-807. PubMed ID: 24992960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.
    Seth PP; Jazayeri A; Yu J; Allerson CR; Bhat B; Swayze EE
    Mol Ther Nucleic Acids; 2012 Sep; 1(10):e47. PubMed ID: 23344239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.